Treatment of Recurrent or Metastatic Submandibular Gland Cancer — Other Histological Subtypes

This page addresses the management of salivary gland cancer of the submandibular gland in patients with other (non-common) histological subtypes presenting with recurrent or metastatic disease.

Clinical Scenario

Salivary gland cancer of the submandibular gland, other histological subtypes, in the setting of recurrent or metastatic disease. This population requires systemic treatment tailored to the palliative intent of therapy.

Treatment Approach (Partial Overview)

Evidence-based management in this setting involves consideration of platinum-based palliative chemotherapy — the full regimen details, sequencing, and eligibility criteria are outlined in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

Consider platinum-based palliative ChT [III, B].

DOI: 10.1016/j.esmoop.2022.100602

View source ↗